Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Europe recommends Novo's Frehemgo and AZ's Klygefa
AstraZeneca snagged a recommendation from the CHMP, setting dual-binding nanobody C5 inhibitor Klygefa up for a formal approval in Europe.
Donavyn Coffey
Sep 18, 2026 11:23am
The Oral GLP-1 Tracker: Holiday takes toll on prescriptions
Sep 18, 2026 11:20am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
A virtual tour through the glitz and glam of Fierce Pharma Week
Sep 18, 2026 11:05am
Closing the gap between innovation and impact
Brought to you by
Diaceutics
US' China deal policy, WCLC, Legend CEO—Fierce Pharma Asia
Sep 18, 2026 10:20am
